← Eichor
Study identifier: NCT05925452 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

To Evaluate the Efficacy and Safety of Genalumab for Injection in the Treatment of Active Systemic Juvenile Idiopathic Arthritis.

Condition: Active Systemic Juvenile Idiopathic Arthritis  ·  Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd.

PhaseNA
Planned participants221
Who can joinAll sexes, 2 Years to 17 Years
Healthy volunteersNo

About this study

A multicenter, randomized Phase II/III clinical study to evaluate the efficacy and safety of GenaKumab in the treatment of active systemic juvenile idiopathic arthritis.

This description comes directly from the study's public registry record.

Talk to the study team

Lijun Tang  ·  +86 18570616501  ·  tanglijun@genscigroup.com

Always discuss trial participation with your own doctor first.

Locations (10)

Children's Hospital Affiliated to Capital Medical UniversityBeijing, Benjing, ChinaRecruiting
Children's Hospital Affiliated to Chongqing Medical UniversityChongqing, Chongqing Municipality, ChinaNot Yet Recruiting
Hunan Children's HospitalChangsha, Hunan, ChinaNot Yet Recruiting
Children's Hospital Affiliated to Nanjing Medical UniversityNanjing, Jiangsu, ChinaNot Yet Recruiting
Children's Hospital of Soochow UniversitySuzhou, Jiangsu, ChinaNot Yet Recruiting
Affiliated Pediatric Hospital of Fudan UniversityShanghai, Shanghai Municipality, ChinaNot Yet Recruiting
Xi'an Children's HospitalXi’an, Shanxi, ChinaNot Yet Recruiting
Chengdu Women and Children's Central HospitalChengdu, Sichuan, ChinaNot Yet Recruiting
Children's Hospital, Zhejiang University School of MedicineHangzhou, Zhejiang, ChinaNot Yet Recruiting
The Second Affiliated Hospital of Wenzhou Medical UniversityWenzhou, Zhejiang, ChinaNot Yet Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05925452